Clinical trials
Cardiovascular Disease Other clinical trials
Below are recruiting cardiovascular disease other clinical trials, each written for real people, not researchers. We’re tracking 777 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT03374215Recruiting
Study hormone causes of high blood pressure in Black adults
This study looks at the body’s hormone signals to understand what causes primary aldosteronism (a condition that can lead to high blood pressure). By comparing clinical results and lab data, researchers hope to improve how the condition is diagnosed and managed, especially in Black participants.
Bethesda, MarylandAges 7–70 - NCT05539781Recruiting
Blood flow and brain function monitoring after carotid procedure
This trial studies how blood flow and brain function change after a carotid artery revascularization procedure (opening a narrowed carotid artery). It may help doctors understand what to expect after treatment, especially in people with significant artery narrowing.
Beijing, Beijing MunicipalityAges 18–85 - NCT07026370Enrolling by invitation
Chinese Health Study: Long-term health follow-up
This study is following up with people who already took part in a large health survey in China. It looks at how multiple health conditions develop over time and why some people stay healthier than others.
Beijing, Beijing MunicipalityAges 20 years+ - NCT06606821RecruitingPhase 4
Tirzepatide for heart health in people with overweight or obesity
This trial tests the weight‑loss medication tirzepatide (Mounjaro) in people who are overweight or have obesity and have stable coronary artery disease. The goal is to see if tirzepatide can reduce dangerous fatty plaque in heart arteries.
CopenhagenAges 18 years+ - NCT07865936Recruiting
Heart health check for fatty liver disease patients
This study looks at heart health in people with fatty liver disease (MASLD) by measuring calcium in the heart's arteries with a special scan, to see if they are at risk for heart problems.
Bangkok, BangkoknoiAges 35–75 - NCT05731986Recruiting
Skin nerve stimulation to raise blood pressure after spinal injury
This study tests whether a device that delivers mild electrical stimulation through the skin can improve low blood pressure after an acute spinal cord injury. It may help reduce episodes of dizziness or faint-feeling caused by blood pressure dropping when you sit up.
West Orange, New JerseyAges 18–75 - NCT03938155Recruiting
Risk check program for older women in Manitoba
This trial looks at how well a health risk assessment can identify heart and blood-vessel problems in women 55 and older. It may help doctors target prevention earlier, which could lower the chance of serious events.
Winnipeg, ManitobaAges 55 years+ - NCT04417387Recruiting
Check genetics to improve heart disease risk prediction
This study looks at whether adding genetic information to a standard NHS Health Check can better predict a person’s risk of coronary artery disease (CAD). If you qualify, you may be asked to provide genetic information to help refine future risk estimates.
LeicesterAges 40–74 - NCT07839741RecruitingPhase 4
Lowering cholesterol with ezetimibe
This trial looks at how well ezetimibe, a medicine that lowers cholesterol, works when taken alone or alongside other cholesterol medicines. It may help people who need extra help lowering their LDL (bad) cholesterol.
PortoAges 18–75 - NCT07641309Recruiting
Health Program for Diabetes, Lung, or Heart Disease
This study measures how a health improvement program helps people with type 2 diabetes, chronic lung disease, or heart disease. Researchers will track your health before and after you participate in the program offered by your local municipality.
FrederiksværkAges 18 years+ - NCT07483502Recruiting
Pre-surgery gut health supplement study for heart patients
This trial tests whether taking a gut health supplement (WellBiome) for six weeks before heart surgery can improve recovery and save the NHS money. It compares the supplement to a placebo (a pill with no active medicine).
Hull, East Riding Of YorkshireAges 50–80 - NCT06949722Recruiting
Can better sleep help your heart?
This study tests if improving poor sleep can reduce your risk of heart disease. You will wear a ring to track your sleep and get support to build healthier sleep habits.
SingaporeAges 40–70 - NCT07107971Recruiting
Drug balloon vs. standard care for fatty heart plaques
This study compares a drug-coated balloon (which releases medicine into the artery) with standard medicines alone for treating fatty plaques in the heart arteries. It is for people who have already had a heart attack and a successful opening of a blocked artery.
AmsterdamAges 18 years+ - NCT06595784Recruiting
COPD and heart disease study
This study looks at people who have both COPD (a long-term lung condition) and a heart problem. The goal is to learn more about how these two conditions affect each other and to help doctors provide better care.
AlexandroupoliAges 35–99 - NCT06959784Enrolling by invitationPhase 4
A study on new diabetes drugs for heart health and remission
This trial tests if newer diabetes medications can reduce heart risk and help achieve diabetes remission in people newly diagnosed with type 2 diabetes. It may be an option if you have not taken diabetes drugs before or stopped them over three months ago, and your blood sugar and weight are in certain ranges.
BeijingAges 30–70 - NCT05991219Recruiting
Rheumatic heart disease screening and prevention study
This study is looking for people living in rural areas of Sindh, Pakistan, to help screen for and prevent rheumatic heart disease. It aims to find and treat the condition early.
Karachi, SindhAges 10–30 - NCT07524335RecruitingPhase 3
Aspirin for early coronary artery disease without symptoms
This trial tests whether taking aspirin can help people who have early signs of coronary artery disease (buildup in heart arteries) but have never had a heart attack or stroke. The goal is to see if aspirin prevents future heart problems in these patients.
Montreal, QuebecAges 40 years+ - NCT06998862RecruitingPhase 3
Colchicine for people with chronic kidney disease
This trial tests whether colchicine, a drug that reduces inflammation, can help prevent further heart problems or strokes in people with moderate chronic kidney disease. You may be eligible if you have kidney disease and have had a heart attack, stroke, or related event in the past.
Madrid, MadridAges 18–99 - NCT07136012RecruitingPhase 3
Olpasiran trial to lower Lp(a) and prevent first heart attack or stroke
This trial tests if olpasiran can lower a type of cholesterol called Lp(a) to help prevent a first major heart attack, stroke, or other heart problems. It is for people at higher risk due to risk factors or early signs of artery disease, but who have not yet had a heart attack or stroke.
Alexander City, AlabamaAges 50–105 - NCT07237685Recruiting
Diabetes and heart artery plaque progression study
This study uses a follow-up CT scan of your heart arteries to see how diabetes-related plaque buildup changes over time. It may help researchers understand how well current diabetes treatments are protecting your heart.
AmsterdamAges 18 years+ - NCT06602934Recruiting
Pneumonia, heart health, and your body's germs
This study looks at how pneumonia affects the long-term health of your heart and lungs by studying the germs that live in your body. It may help doctors understand why some people get worse and how to better protect your heart after a serious infection.
AngersAges 18–80 - NCT07286578Recruiting
Using heart CT scans to guide treatment for blocked arteries
This trial is testing whether a special heart CT scan (coronary CT angiography) can help doctors better understand and treat calcium buildup in your heart arteries. If you have a type of heart disease that might need a stent or other procedure, this study could help decide the best approach.
Boston, MassachusettsAges 18–85 - NCT06297291Recruiting
Blood pressure study after kidney nerve treatment
This study looks at how well a procedure that uses sound waves to calm kidney nerves (renal denervation) lowers blood pressure over time. It may help people whose blood pressure stays high despite taking medication.
Long Beach, CaliforniaAges 18 years+ - NCT06087848RecruitingPhase 1/Phase 2
StromaForte stem cell therapy for heart event prevention
This trial tests a stem cell product called StromaForte to see if it can reduce cardiovascular events like heart attacks in people with stable medical conditions. It may help if you have heart or blood vessel issues that have been stable for at least six months.
Nassau, The BahamasAges 25–85
Hear when a new Cardiovascular Disease Other trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for cardiovascular disease other?
- Yes. Clin2 currently lists 777 recruiting cardiovascular disease other studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a cardiovascular disease other trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a cardiovascular disease other trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.